All transcriptome data files are available from the NCBI Sequence Read Archive database (accession number SRP092778).

Introduction {#sec001}
============

Large yellow croaker (*Larimichthys crocea*) is one of the most important aquaculture species in China, with the annual yield exceeding any other net-cage-farmed marine fish species \[[@pone.0170958.ref001]\]. However, the diseases caused by bacteria, such as *Vibrio parahaemolyticus* \[[@pone.0170958.ref002]\], *Vibrio alginolyticus* \[[@pone.0170958.ref003]\], and *Aeromonas hydrophila* \[[@pone.0170958.ref004]\], outbreak frequently and result in tremendous economic losses in large yellow croaker aquaculture industry. Chemotherapeutants and antibiotics are useful for preventing bacterial infection, but long term treatment often leads to resistance and environmental pollution \[[@pone.0170958.ref005]\]. Vaccination is an effective and safe strategy for combating bacterial diseases in fish \[[@pone.0170958.ref006]\]. A number of vaccines are commercially available for use in the aquaculture industry, such as formalin-inactivated *Yersinia ruckeri* \[[@pone.0170958.ref007]\], *Aeromonas salmonicida* \[[@pone.0170958.ref008]\], and *Vibrio anguillarum* \[[@pone.0170958.ref009]\]. The effects of vaccines were mainly evaluated by serum or mucus antibody titers and survival rate \[[@pone.0170958.ref010]\]. Recently, several studies on the gene expression changes have been performed to understand the immune response to bacterial vaccines in fish. In Atlantic salmon (*Salmo salar*), the increased expressions of antibacterial proteins and proteases were observed after vaccination with live *Aeromonas salmonicida* \[[@pone.0170958.ref011]\]. In zebrafish (*Danio rerio*), multiple pathways including acute phase response, complement activation, and antigen processing and presentation were remarkably affected during the early stage of vaccination \[[@pone.0170958.ref012]\]. The genes involved in inflammation and antioxidant defense were also up-regulated in Atlantic cod (*Gadus morhua*) following vaccination with heat-killed *Vibrio anguillarum* \[[@pone.0170958.ref013]\].

An inactivated trivalent bacterial vaccine, consisting of *V*. *alginolyticus*, *V*. *parahaemolyticus*, and *A*. *hydrophila*, was developed and provided an effective protection against bacterial infection in large yellow croaker, with a relative percent survival (RPS) of 88.9% \[[@pone.0170958.ref014]\]. This trivalent bacterial vaccine has been used to study the expression patterns of immune-relevant genes in large yellow croaker, such as goose-type lysozyme \[[@pone.0170958.ref015]\], caspase 9 \[[@pone.0170958.ref016]\], C-type lectin-like receptor \[[@pone.0170958.ref017]\], CXCL8 \[[@pone.0170958.ref018]\], CXCL13 \[[@pone.0170958.ref019]\], and stefin \[[@pone.0170958.ref020]\], indicating that this bacterial vaccine could induce the expression of innate immunity molecules in large yellow croaker. Currently, high-throughput RNA sequencing (RNA-seq) technology provides a powerful and cost-effective approach to understand the immune response evoked by different stimulus. For instance, RNA-seq was applied to identify immune-candidate genes, infection markers, and putative signaling pathways in rainbow trout (*Oncorhynchus mykiss*) \[[@pone.0170958.ref021]\], tilapia (*Oreochromis niloticus*) \[[@pone.0170958.ref022]\], and grass carp (*Ctenopharyngodon idellus*) \[[@pone.0170958.ref023]\] after bacterial infection.

Here, we used RNA-seq to examine the transcriptional profiles of the large yellow croaker spleens at early time points (0, 24, and 72 h) following immunization with inactivated trivalent vaccine (*V*. *alginolyticus*, *V*. *parahaemolyticus* and *A*. *hydrophila*). A series of differentially expressed genes (DEGs) were identified and found to be involved in the innate immunity and acquired immunity processes. Moreover, quantitative real-time PCR was used to verify expression changes of partial immune-relevant genes. These data provide valuable information to better understand the early immune response after vaccination in large yellow croaker.

Materials and Methods {#sec002}
=====================

Ethics statement {#sec003}
----------------

All handling of fish was approved by the Institutional Animal Care and Use Committee of Fujian Province, and performed in strict accordance with the Regulations for the Administration of Affairs Concerning Experimental Animals, under protocol license number: SYXK (MIN) 2007--0004. All surgeries were carried out under Tricaine-S anesthesia, and all efforts were made to minimize suffering.

Inactivated trivalent bacterial vaccine and fish samples {#sec004}
--------------------------------------------------------

The *V*. *parahaemolyticus*, *V*. *alginolyticus* and *A*. *hydrophila* were isolated from the diseased large yellow croaker previously \[[@pone.0170958.ref014]\]. For vaccine preparation, the three bacteria were cultured in Luria-Bertain (LB) for 16 h in a shaker incubator (180 rpm) at 30°C, respectively. After collected and washed with the sterilized phosphate-buffered saline (PBS, pH 7.4), *V*. *parahaemolyticus*, *V*. *alginolyticus* and *A*. *hydrophila* were mixed at same proportion (1.0×10^9^ CFU/mL each) and inactivated with 0.5% formalin (v/v) at 4°C for 4 h. The mixed inactivated trivalent vaccine was washed with the sterilized PBS. To evaluate the effectiveness of the formalin-inactivation, 50 μL of formalin-inactivated suspensions were spread on LB agar (1.5%, w/v) and incubated at 37°C for 24 h. No bacterial growth was observed, indicating that the bacterial cells were completely inactivated.

Large yellow croakers (length: 20 ± 1.76 cm; weight: 100 ± 21.5 g) were obtained from the Mari-culture farm in Lianjiang, Fuzhou, China. The fish were maintained at 20°C in aerated water tanks with a flow-through seawater supply. After one week of acclimatization, a group of 30 fish were injected intraperitoneally with inactivated trivalent bacterial vaccine (1.0×10^9^ CFU/mL each) at a dose of 0.2 mL/100 g fish. The spleen tissues were harvested from 10 large yellow croakers at each time point (0, 24, and 72 h) after vaccination.

RNA extraction, library preparation, and sequencing {#sec005}
---------------------------------------------------

Total RNA was isolated from pooled spleen tissues of 6 fish sampled at each time point for RNA-seq analysis using TRIZOL® Reagent (Invitrogen, USA), respectively, and treated with RNase-free DNase I (Takara, China) at 37°C for 1 h to remove residual genomic DNA. The RNA samples (5 μg each) were used to construct RNA-seq libraries by Illumina mRNA-Seq Prep Kit, and the libraries were sequenced by paired-end sequencing on the Illumina HiSeq 2000 sequencing platform (Illumina, USA).

Identification of the differentially expressed genes {#sec006}
----------------------------------------------------

Clean reads were picked out from the raw reads of each library following removal of the reads containing adaptor sequences, reads with an N (unknown bases in read) percentage higher than 10%, and low quality reads (\> 50% of bases with a quantity score Q-value ≤ 10) using an in-house C^++^ program. The clean reads were aligned to the large yellow croaker genome (**JRPU00000000**) \[[@pone.0170958.ref024]\] using the software Burrows-Wheeler Aligner (BWA, parameter: -o 1 -e 63 -i 90 -L -k 2 -l 31 -t 4 -q 10) \[[@pone.0170958.ref025]\], and mapped to the coding sequences (CDS) of large yellow croaker genome using Bowtie2 (Parameter: -q \--phred64 \--sensitive \--dpad 0 \--gbar 99999999 \--mp 1,1 \--np 1 \--score-min L,0,-0.1 -I 1 -X 1000 \--no-mixed \--no-discordant -p 1 -k 200) \[[@pone.0170958.ref026]\]. The gene expression levels were calculated based on FPKM (fragments per kilobase of transcripts per million fragments mapped) values by using RSEM (RNA Seq by Expectation Maximization) with default setting \[[@pone.0170958.ref027]\]. Comparisons of gene expression difference between control (0 h) and other time points after vaccination (24 and 72 h) were performed by strict Poisson distribution algorithm. Genes with the absolute value of the log~2~Ratio ≥ 1 and FDR (false discovery rate) ≤ 0.001 were defined as DEGs \[[@pone.0170958.ref028]\].

Gene ontology and kyoto encyclopedia of genes and genomes (KEGG) analysis {#sec007}
-------------------------------------------------------------------------

All the DEGs were mapped to the gene ontology (GO) database (<http://www.geneontology.org/>) using Blast2GO software \[[@pone.0170958.ref029]\]. KEGG Orthology (KO) was carried out by BLASTx based on the KEGG database (<http://www.genome.jp/kegg/>). Finally, GO and KO enrichment analysis were performed according to the hypergeometric distribution test. For GO enrichment analysis, all of the *P*-values were performed with Bonferroni correction. We have selected a corrected *P*-value of 0.05 as a threshold to determine significant enrichment of the gene sets. In contrast, for KO enrichment analysis, we have used a Q-value of 0.05 as the threshold to determine significant enrichment of the gene sets.

Quantitative real-time PCR {#sec008}
--------------------------

Quantitative real-time PCR was performed using Mastercycler epgradient realplex4 (Eppendorf, Germany) with SYBR Green (Takara, China). Primer sets were designed based on the coding sequences of identified genes in large yellow croaker genome and specific PCR product of each gene was observed on the agarose gels (**[S1 Table](#pone.0170958.s002){ref-type="supplementary-material"}** and **[S1 Fig](#pone.0170958.s001){ref-type="supplementary-material"}**). Total RNA was extracted from pooled spleen tissues of three fish sampled at each time point (0, 24, and 72 h) after vaccination for Real-time PCR analysis. Real-time PCR was performed in a total volume of 20 μL, and cycling conditions were 95°C for 1 min, followed by 40 cycles of 95°C for 15 s, 58°C for 15 s, 72°C for 20 s. Each real-time PCR assay was repeated three times with different batches of fish. The expression level of target gene was normalized by that of β-actin using the 2^-ΔΔCT^ method \[[@pone.0170958.ref030]\]. The fold change was calculated as the average expression level of target gene in trivalent vaccine-challenged samples at each time point (24 and 72 h) divided by that in the control sample (0 h). The data of real-time PCR was analyzed using GraphPad Prism 5 software and expressed as the standard error of the mean (SEM). Two-tailed Student's *t* test was used for the significance test between the experimental group and the control group. A *P*-value \<0.05 was considered to be statistically significant.

Results {#sec009}
=======

Sequence analysis of the transcriptomes {#sec010}
---------------------------------------

Three transcriptomes were sequenced from pooled spleens of large yellow croaker after vaccination. More than 5.4 gigabase (Gb) of data were generated in each library (**[Table 1](#pone.0170958.t001){ref-type="table"}**). After eliminating adaptor sequences and low-quality sequences, a total of 63,568,408, 60,346,074, and 60,445,278 clean reads were obtained from the three libraries (0, 24, and 72 h), respectively. Average 70% of the clean reads could be mapped to the genome of large yellow croaker with 19,648, 19,106, and 19,145 genes, respectively. Raw sequencing reads data has been deposited in SRA (NCBI) under the accession number of SRP092778.

10.1371/journal.pone.0170958.t001

###### Summary of the data for transcriptomes.

![](pone.0170958.t001){#pone.0170958.t001g}

  Sample   Insert size (bp)   Read length (bp)   Number of clean reads   Clean bases (bp)   Alignment togenome (%)   Alignment to CDS (%)
  -------- ------------------ ------------------ ----------------------- ------------------ ------------------------ ----------------------
  0 h      200                90_90              63,568,408              5,721,156,720      70.57                    41.42
  24 h     200                90_90              60,346,074              5,431,146,660      71.41                    42.03
  72 h     200                90_90              60,445,278              5,440,075,020      70.54                    41.49

Analysis of differential expression genes {#sec011}
-----------------------------------------

The gene expression levels were calculated based on FPKM values, and gene expression difference was analyzed between each time point (24 and 72 h) after vaccination and control (0 h). At 24 h, 2,789 genes were differentially expressed (log~2~Ratio ≥ 1, FDR ≤ 0.001), including 1,132 up-regulated genes and 1,657 down-regulated genes (**[Fig 1](#pone.0170958.g001){ref-type="fig"}**). Meanwhile, a total of 1,511 differentially expressed genes were found at 72 h after vaccination, including 842 up-regulated genes and 669 down-regulated genes. All the differentially expressed genes were provided in **[S2 Table](#pone.0170958.s003){ref-type="supplementary-material"}**.

![Statistic of differentially expressed genes (DEGs) at different time points after vaccination.\
The comparisons of gene expression difference between control (0 h) and each time point after vaccination (24 and 72 h) were performed based on FPKM values. The significant DEGs are defined as log~2~Ratio ≥ 1 and FDR ≤ 0.001.](pone.0170958.g001){#pone.0170958.g001}

Gene ontology and KEGG enrichment analysis of DEGs {#sec012}
--------------------------------------------------

Gene ontology functional enrichment analysis for DEGs at 24 h (or 72 h) showed that most of DEGs were classified into three major functional categories: ''biological process", ''molecular function", and ''cellular component", represented by 606 (or 389), 643 (or 390), and 420 (or 283) genes, respectively (**[S3 Table](#pone.0170958.s004){ref-type="supplementary-material"}**). The largest subcategories were "cellular processes" (299 or 223 genes), "catalytic activity" (390 or 235 genes), and "cell" (299 or 223 genes) at 24 h or 72 h in corresponding major functional categories. Moreover, two immune-relevant subcategories, "response to stimulus" (120 or 57 genes) and "immune system process" (21 or 13 genes) were also enriched (**[Fig 2](#pone.0170958.g002){ref-type="fig"}**).

![Enrichment of Gene Ontology classifications for the DEGs.\
The DEGs were annotated into three major functional categories: biological process, cellular component, and molecular function. The X-axis indicates the names of GO terms (2nd level) and the Y-axis indicates the number of DEGs. A, Gene Ontology classifications of DEGs at 24 h after vaccination; B, Gene Ontology classifications of DEGs at 72 h after vaccination.](pone.0170958.g002){#pone.0170958.g002}

KEGG analysis showed that 439 (or 279) DEGs were assigned to 216 (or 173) pathways at 24 (or 72 h) after vaccination, respectively (**[S4 Table](#pone.0170958.s005){ref-type="supplementary-material"}**). Immune-relevant KEGG pathways were listed in **[Table 2](#pone.0170958.t002){ref-type="table"},** including cytokine-cytokine receptor interaction (17 or 8 genes), T cell receptor signaling pathway (10 or 4 genes), NF-κB signaling pathway (14 or 4 genes), and antigen processing and presentation (8 or 4 genes) at 24 or 72 h. The metabolic pathway had the largest number of DEGs (66 or 39 genes, **[S4 Table](#pone.0170958.s005){ref-type="supplementary-material"}**), indicating that vaccination not only can activate immune-relevant pathways, but also may influence metabolic process.

10.1371/journal.pone.0170958.t002

###### Immune-relevant KEGG pathways.

![](pone.0170958.t002){#pone.0170958.t002g}

  Pathway ID   Pathway name                                Number of all [\*](#t002fn001){ref-type="table-fn"} components   Number of DEGs (24 h)   Number of DEGs (72 h)
  ------------ ------------------------------------------- ---------------------------------------------------------------- ----------------------- -----------------------
  ko04020      Calcium signaling pathway                   120                                                              21                      5
  ko04514      Cell adhesion molecules (CAMs)              75                                                               18                      6
  ko04060      Cytokine-cytokine receptor interaction      73                                                               17                      8
  ko04142      Lysosome                                    69                                                               16                      4
  ko04010      MAPK signaling pathway                      110                                                              16                      6
  ko04145      Phagosome                                   101                                                              15                      7
  ko04144      Endocytosis                                 133                                                              15                      9
  ko04064      NF-kappa B signaling pathway                64                                                               14                      4
  ko04670      Leukocyte transendothelial migration        84                                                               14                      3
  ko04062      Chemokine signaling pathway                 80                                                               11                      4
  ko04666      Fc gamma R-mediated phagocytosis            82                                                               11                      4
  ko04660      T cell receptor signaling pathway           61                                                               10                      4
  ko04650      Natural killer cell mediated cytotoxicity   50                                                               9                       2
  ko04612      Antigen processing and presentation         25                                                               8                       4
  ko04120      Ubiquitin mediated proteolysis              65                                                               8                       4

\*: Be based on each relevant KEGG pathway.

Annotation of immune-relevant genes {#sec013}
-----------------------------------

To better understand the early immune response of large yellow croaker immunized with bacterial vaccine, the immune-relevant DEGs were collected and clustered (**[Table 3](#pone.0170958.t003){ref-type="table"}**). Lots of important elements of innate immunity were significantly up-regulated at 24 or 72 h after vaccination, including complement components (C2, C3, C7, HF, BF, DF), coagulation system factors (F7, F8, THBS1), lectins (CLEC4E, COLEC12, CLEC17A, F-lectin 1, F-lectin 5, PTX), transferrins (TF, HP), antimicrobial proteins (BPI, lysG, Hep-1), pattern recognition receptors (TLR5M, MMR1, CTLR, PGRP-SC2, NLRP1, NLRP3, **[Fig 3](#pone.0170958.g003){ref-type="fig"}**), signal transducers (IκBα, ERK), transcriptional factors (RelB, AP-1), interleukins and interleukin receptors (IL-1β, IL-6, IL-10, IL-12, IL-27, IL-34, IL-1R, IL-12R, IL-22R), chemokines and chemokine receptors (CCL4, CCL19, CCL20, CCR1, CXCR3), apoptosis-related genes (CASP8, CASP10, BAX, BCL6), cathepsin (CTSL, CTSO), and other immune molecules (TNF-α, MMP-19).

![Pattern-recognition receptors and putative signaling pathways.\
The predicted pathway was constructed based on the references \[[@pone.0170958.ref043], [@pone.0170958.ref056]\]and the knowledge of mammalian species. Red background indicates significantly up-regulated expression, and yellow background indicates no significant differential expression. The arrows represent promotion, the solid lines indicate direct relationships between genes, and the dashed lines indicate that more than one step is involved in the process. After binding to flagellin, TLR5M triggers sequential recruitment of MyD88, members of IRAK (interleukin-1 receptor-associated kinase) family and TRAF6 that resulted in activation of nuclear factor NF- κB and AP-1, thus inducing production of inflammatory cytokines such as IL-1β, IL-6, IL-12, and TNF-α. After recognizing corresponding ligands (LPS, Muramyl Dipeptide, or bacterial RNA), NLRP1 or NLRP3 can bind with their adaptor proteins ASC and capase-1 to form the inflammasome complex, and the latter promotes cleavage and secretion of biologically active pro-inflammatory cytokine IL-1β.](pone.0170958.g003){#pone.0170958.g003}

10.1371/journal.pone.0170958.t003

###### Immune-relevant DEGs found in the trivalent vaccine-induced transcriptome.

![](pone.0170958.t003){#pone.0170958.t003g}

  Accession number                                     Description                                                         Gene name    log~2~ratio (24 h/0 h)   *P*-value   log~2~ratio (72 h/0 h)   *P*-value
  ---------------------------------------------------- ------------------------------------------------------------------- ------------ ------------------------ ----------- ------------------------ -----------
  **Innate defense molecules**                                                                                                                                                                        
  Complement and coagulation cascades                                                                                                                                                                 
  EH28_12969                                           Complement component 2                                              C2           -0.05                    4.02E-01    1.03                     3.83E-71
  EH28_04156                                           Complement component 3                                              C3           1.64                     0.00E+00    -0.07                    0.00E+00
  EH28_10105                                           Complement component 7                                              C7           3.38                     4.54E-148   1.57                     3.93E-18
  EH28_10318                                           Complement factor B                                                 BF           2.26                     2.58E-08    1.67                     2.39E-04
  EH28_11857                                           Complement factor D                                                 DF           1.19                     0.00E+00    0.97                     4.00E-308
  EH28_04424                                           Complement factor H                                                 HF           0.24                     1.02E-76    1.25                     1.22E-108
  EH28_00866                                           Coagulation factor VII                                              F7           1.37                     2.64E-01    2.24                     3.10E-02
  EH28_13616                                           Coagulation factor VIII                                             F8           2.73                     0.00E+00    2.29                     0.00E+00
  EH28_04699                                           Thrombospondin-1                                                    THBS1        3.28                     0.00E+00    0.46                     2.46E-04
  Lectins                                                                                                                                                                                             
  EH28_17226                                           C-type lectin domain family 4 member E                              CLEC4E       3.07                     6.05E-169   1.98                     4.42E-48
  EH28_19458                                           C-type lectin domain family 17 member A                             CLEC17A      0.69                     3.39E-04    1.07                     2.40E-09
  EH28_17225                                           Collectin-12                                                        COLEC12      6.56                     5.78E-79    4.26                     5.85E-14
  EH28_00227                                           Fucolectin-1                                                        F-lectin 1   -0.78                    1.13E-06    1.67                     2.17E-53
  EH28_08704                                           Fucolectin-5                                                        F-lectin 5   -0.82                    2.00E-02    1.02                     8.22E-05
  EH28_17496                                           Pentraxin-related protein PTX3                                      PTX3         3.19                     1.03E-09    1.9                      4.52E-03
  EH28_05767                                           Pentraxin-4                                                         PTX4         4.50                     4.21E-195   3.34                     3.45E-70
  Antibacterial proteins                                                                                                                                                                              
  EH28_24821                                           Bactericidal permeability-increasing protein                        BPI          0.49                     1.33E-18    1.32                     1.7E-167
  EH28_14666                                           Haptoglobin                                                         HP           4.36                     0.00E+00    1.79                     1.86E-35
  EH28_06996                                           Hepcidin-1                                                          Hep-1        3.34                     1.10E-57    1.02                     1.89E-03
  EH28_15797                                           Lysozyme g                                                          LysG         1.43                     4.28E-31    1.34                     3.20E-26
  EH28_25262                                           Serotransferrin                                                     TF           6.79                     4.37E-92    4.9                      8.76E-23
  **Pattern recognition receptor signaling pathway**                                                                                                                                                  
  Pattern recognition receptors                                                                                                                                                                       
  EH28_23426                                           C-type lectin receptor                                              CTLR         2.12                     4.13E-26    0.82                     1.30E-03
  EH28_21627                                           Macrophage mannose receptor 1                                       MMR1         1.17                     8.80E-112   1.26                     1.02E-132
  EH28_00392                                           NACHT, LRR and PYD domains containing protein 1                     NLRP1        1.09                     4.42E-02    0.47                     5.78E-02
  EH28_22777                                           NACHT, LRR and PYD domains containing protein 3                     NLRP3        1.71                     3.70E-37    1.42                     3.70E-37
  EH28_21234                                           Peptidoglycan-recognition protein SC2                               PGRP-SC2     15.68                    6.27E-33    13.46                    1E-07
  EH28_09444                                           Toll-like receptor 3                                                TLR3         -3.05                    1.98E-81    -1.95                    1.39E-48
  EH28_18671                                           Toll-like receptor 5                                                TLR5M        3.71                     1.07E-46    1.54                     8.47E-08
  Adaptor and signal transducers                                                                                                                                                                      
  EH28_14997                                           Apoptosis-associated speck-like protein containing a CARD           ASC          1.10                     5.17E-26    0.59                     4.81E-07
  EH28_25086                                           Mitogen-activated protein kinase 15                                 ERK          1.74                     2.59E-08    0.62                     1.05E-01
  EH28_14297                                           NF-kappa-B inhibitor alpha                                          IκBα         1.90                     0.00E+00    0.34                     9.45E-11
  EH28_20652                                           Putative ATP-dependent RNA helicase DHX58                           LGP-2        -1.09                    9.02E-89    -0.35                    2.80E-13
  EH28_12674                                           Rho guanine nucleotide exchange factor 12                           LARG         1.61                     7.84E-61    0.51                     2.00E-05
  EH28_06883                                           Transcription factor AP-1                                           Ap-1         2.13                     7.56E-89    0.12                     4.53E-01
  **Cytokines and Cytokine receptors**                                                                                                                                                                
  Cytokines                                                                                                                                                                                           
  EH28_13993                                           C-C motif chemokine 4                                               CCL4         2.46                     2.86E-87    2.52                     1.91E-92
  EH28_23981                                           C-C motif chemokine 19                                              CCL19        2.64                     0.00E+00    0.77                     5.43E-54
  EH28_25343                                           C-C motif chemokine 20                                              CCL20        3.71                     5.25E-09    1.33                     1.95E-01
  EH28_21923                                           Interleukin-1 beta                                                  IL-1β        5.16                     5.92E-91    3.3                      3.22E-19
  EH28_25178                                           Interleukin-6                                                       IL-6         5.19                     1.09E-37    2.41                     5.79E-04
  EH28_18941                                           Interleukin-10                                                      IL-10        4.14                     1.73E-14    3.02                     5.09E-24
  EH28_23359                                           Interleukin-12 subunit beta                                         IL-12        3.64                     1.55E-28    0.43                     4.72E-01
  EH28_14432                                           Interleukin-27 subunit beta                                         IL-27        1.80                     1.67E-15    1.19                     2.61E-06
  EH28_03825                                           Interleukin-34                                                      IL-34        1.03                     1.39E-06    1.06                     6.59E-07
  EH28_07798                                           Interferon gamma                                                    IFN-γ        1.65                     2.82E-04    1.93                     8.9E-06
  EH28_05037                                           Tumor necrosis factor alpha                                         TNF-α        2.07                     5.97E-04    0.50                     5.39E-01
  Cytokine receptors                                                                                                                                                                                  
  EH28_03117                                           C-X-C chemokine receptor type 1                                     CXCR1        1.92                     1.33E-226   0.64                     2.45E-17
  EH28_21430                                           C-X-C chemokine receptor type 3                                     CXCR3        1.19                     6.26E-47    0.55                     3.52E-09
  EH28_18535                                           Interleukin-1 receptor type 2                                       IL-1R        7.32                     0.00E+00    4.62                     3.18E-99
  EH28_07447                                           Interleukin-12 receptor subunit beta-2                              IL-12R       1.26                     8.92E-122   0.27                     4.40E-05
  EH28_04343                                           Interleukin-22 receptor subunit alpha-2                             IL-22R       1.65                     8.52E-05    0.19                     7.50E-01
  **Apoptosis-related genes**                                                                                                                                                                         
  EH28_19418                                           Apoptosis facilitator Bcl-2-like protein 14                         BCL2L14      1.97                     1.60E-34    1.55                     4.60E-19
  EH28_07897                                           Apoptosis regulator BAX                                             BAX          1.04                     5.90E-05    1.22                     1.05E-06
  EH28_10711                                           B-cell lymphoma 6 protein                                           BCL6         1.27                     1.39E-31    0.45                     3.09E-04
  EH28_18771                                           Caspase-8                                                           CASP8        1.13                     2.03E-24    0.53                     2.58E-05
  EH28_18769                                           Caspase-10                                                          CASP10       1.07                     2.91E-22    1.02                     5.27E-20
  **Antigen processing and presentation**                                                                                                                                                             
  EH28_19874                                           Antigen peptide transporter 1                                       TAP1         2.38                     0.00E-00    1.21                     5.21E-80
  EH28_06369                                           Antigen peptide transporter 2                                       TAP2         1.28                     1.66E-71    0.90                     1.21E-31
  EH28_09011                                           Calreticulin                                                        CLAR         1.53                     1.60E-01    1.47                     2.12E-178
  EH28_06817                                           Cathepsin L                                                         CTSL         1.23                     1.24E-168   1.12                     1.03E-131
  EH28_11008                                           Cathepsin O                                                         CTSO         1.10                     3.35E-07    0.67                     4.33E-03
  EH28_11216                                           Endoplasmic reticulum aminopeptidase 1                              ERAP1        1.32                     6.11E-86    0.86                     6.17E-32
  EH28_24090                                           Endoplasmic reticulum aminopeptidase 2                              ERAP2        1.76                     1.99E-92    0.90                     3.73E-19
  EH28_14158                                           Heat shock protein 70KDa-4                                          HSP70        1.35                     1.61E-47    0.83                     4.94E-16
  EH28_21169                                           HLA class II histocompatibility antigen gamma chain                 MHC- II      -0.19                    1.42E-36    -0.71                    0.00E+00
  EH28_17090                                           Lysosome-associated membrane glycoprotein 1                         LAMP-1       2.08                     0.00E+00    1.13                     8.36E-100
  EH28_25045                                           Lysosomal thioesterase PPT2-A                                       PPT2         1.53                     1.00E-05    0.74                     7.00E-02
  EH28_00289                                           Major histocompatibility complex, class I                           MHC-I        0.75                     2.09E-299   0.32                     3.49E-125
  EH28_18380                                           Proteasome activator subunit 1                                      PA28α        1.11                     9.93E-113   1.12                     1.05E-114
  EH28_02969                                           Proteasome activator complex subunit 2                              PA28β        1.55                     2.06E-202   1.2                      5.77E-106
  EH28_21964                                           Proteasome subunit alpha type-1                                     PSMA1        1.24                     6.62E-118   1.18                     9.09E-105
  EH28_21059                                           Proteasome subunit alpha type-4                                     PSMA4        1.25                     1.15E-66    1.37                     1.01E-82
  EH28_10635                                           Proteasome subunit beta type-2                                      PSMB2        1.28                     1.22E-69    1.37                     2.58E-82
  EH28_20274                                           Proteasome subunit beta type-7                                      PSMB7        1.38                     1.19E-82    0.95                     7.43E-34
  EH28_19428                                           Tapasin                                                             TAPBP        1.06                     1.35E-39    0.38                     2.62E-09
  **TCR signaling pathway**                                                                                                                                                                           
  EH28_05511                                           CD3 gamma chain                                                     CD3γ         -1.20                    2.01E-12    -0.41                    3.65E-03
  EH28_19424                                           Protein kinase C theta type                                         PKCθ         -0.92                    6.35E-10    -0.34                    1.01E-02
  EH28_04099                                           Pyruvate dehydrogenase kinase isozyme 2                             PDK          -1.52                    2.24E-118   -1.33                    5.55E-97
  EH28_02274                                           T-cell receptor alpha chain V region                                TCRα         -1.28                    6.49E-05    -0.66                    2.06E-02
  EH28_23685                                           T-cell receptor beta chain T17T-22                                  TCRβ         -1.18                    1.13E-23    0.02                     9.01E-01
  EH28_17224                                           T-cell surface glycoprotein CD4                                     CD4          -1.85                    2.66E-42    -0.31                    2.35E-03
  EH28_09327                                           T-cell surface glycoprotein CD8 beta chain                          CD8β         -1.70                    1.38E-02    -1.00                    9.95E-02
  EH28_16421                                           Tyrosine-protein kinase Fyn                                         FYN          -1.07                    9.37E-25    -0.71                    2.86E-13
  EH28_09736                                           Tyrosine-protein kinase ZAP-70                                      ZAP-70       -1.44                    2.35E-09    0.18                     3.62E-01
  EH28_23772                                           1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1   PLC-y1       -1.33                    8.40E-40    -0.62                    2.70E-12

Additionally, many adaptive immune-relevant genes, such as proteasome molecules (PA28, PSMA, PSMB), antigen processing-related genes (CLAR, TAP, TAPBP, HSP70, **[Fig 4](#pone.0170958.g004){ref-type="fig"}**), and regulatory factors (IFN-γ, IL-10, TNF-α) were up-regulated after vaccination, whereas T cell receptor (TCR) signaling molecules (CD3γ, CD4, CD8, TCRα, TCRβ, FYN, ZAP-70, PLC-γ1, **[Table 3](#pone.0170958.t003){ref-type="table"}**), and some immunoglobulins (Ig heavy chain V region, Ig heavy chain V-III region CAM, Ig heavy chain V-III region HIL, Ig kappa chain V-IV region JI) were down-regulated (**[S2 Table](#pone.0170958.s003){ref-type="supplementary-material"}**).

![Putative antigen processing and presentation pathway.\
The predicted antigen processing and presentation pathway of large yellow croaker was constructed based on the knowledge of mammalian species. Red background indicates significantly up-regulated expression, and yellow background indicates no significant differential expression. The arrows represent promotion, the solid lines indicate direct relationships between genes, and the dashed lines indicate that more than one step is involved in the process. Bacterial antigens are internalized into host cells via phagosomes or endosomes. Specifically, the antigenic peptides are degraded in the cytoplasm by proteasome, and then transported to the endoplasmic reticulum by TAP and loaded onto MHC-I molecules with the help of ERAP, TAP, TAPBP, and CLAR. Antigenic peptides can also be captured and degraded in endosome and lysosome with the help of CTS, HSP70, and PPT2, and then loaded onto MHC-II molecules.](pone.0170958.g004){#pone.0170958.g004}

Verification of the expression changes of partial immune-relevant genes {#sec014}
-----------------------------------------------------------------------

Partial DEGs were validated by quantitative real-time PCR. The mRNA transcripts of C3, CLEC4E, F-lectin 1, LysG, Hep-1, TLR5M, AP-1, IL-1β, IL-12, TNF-α, TAP1, PSMA1, CTSL, and CTSO were observably increased at 24 or 72 h after vaccination, while the expression levels of TCRβ were down-regulated (**[Fig 5](#pone.0170958.g005){ref-type="fig"}**). Fold changes of those genes from quantitative real-time PCR were well corresponding to the results of RNA-seq expression analysis, supporting the reliability of the transcriptome data.

![Real-time PCR analysis of selected DEGs.\
Real-time PCR was used to validate DEGs associated with innate defense (A), ligand recognition and signal transduction (B), antigen processing and presetation and TCR signaling pathway (C). The expression levels of target gene were expressed relative to those of β-actin in each sample using the 2^-ΔΔCT^ method. Two-tailed Student's *t* test was used for the significance test analysis, ^\*^*P* \< 0.05, ^\*\*^*P* \< 0.01.](pone.0170958.g005){#pone.0170958.g005}

Discussion {#sec015}
==========

To date RNA-seq based transcriptome profiling has been widely used in fish for identifying host determinants of response to bacterial infection \[[@pone.0170958.ref022], [@pone.0170958.ref023], [@pone.0170958.ref031]--[@pone.0170958.ref033]\]. In previous study, we have demonstrated that *A*. *hydrophila* infection could activate Toll-like receptor, JAK-STAT, and MAPK pathways, while inhibit TCR signaling pathway at the early period in large yellow croaker \[[@pone.0170958.ref034]\]. In this study, we analyzed the spleen transcriptome profiles of large yellow croaker after vaccination and found abundant DEGs were involved in innate defense, ligand recognition, antigen processing, and TCR signaling processes.

Innate immune response is considered as the first line of host defense in opposing pathogenic infection in fish. The components of the innate defense are evolutionarily conserved in organisms, including antimicrobial peptides, lysozymes, complement, lectins, and transferrins \[[@pone.0170958.ref035]\]. In this study, the expression of several innate defense molecules was increased obviously after vaccination (**[Table 3](#pone.0170958.t003){ref-type="table"})**. Their up-regulations were further confirmed by real-time PCR, which were well corresponding to the results from transcriptome analysis (**[Fig 5A](#pone.0170958.g005){ref-type="fig"}).** The similar findings were also found in the studies on Atlantic salmon \[[@pone.0170958.ref011]\]and Atlantic cod \[[@pone.0170958.ref013]\], indicating that bacterial vaccine immunization could significantly increase the expression of innate immunity molecules in fish. The activation of complement system usually initiates a cascade of biochemical reactions, resulting in antigen elimination via cell membrane lysis \[[@pone.0170958.ref036]\]. C3 and C7 of large yellow croaker have been proved to participate in the response to bacterial challenge \[[@pone.0170958.ref037], [@pone.0170958.ref038]\]. Lectins possess binding activity towards carbohydrate residues located on bacterial surfaces and aid neutralization of pathogens \[[@pone.0170958.ref039]\]. The transferrins, lysozymes, and antibacterial peptides function as the growth inhibitors of bacteria against the infection of bacterial pathogens \[[@pone.0170958.ref015], [@pone.0170958.ref040], [@pone.0170958.ref041]\]. These data suggest that immunization with trivalent vaccine intensely enhances the innate defense of large yellow croaker.

The activation of innate immune system against invading microbes mainly relies on the recognition of microbial components by pattern-recognition receptors (PRRs) \[[@pone.0170958.ref042]\]. Several PRRs, including TLR5M, NLRP1, NLRP3, MMR1, PGRP-SC2, and CTLR were up-regulated significantly after vaccination (**[Table 3](#pone.0170958.t003){ref-type="table"}** and **[Fig 5B](#pone.0170958.g005){ref-type="fig"}**). TLR5M is known to recognize bacterial flagellin, signal through MyD88 and TRAF6, trigger the activation of MAPK and NF-κB, and induce inflammatory factors production \[[@pone.0170958.ref043]\]. Due to *V*. *alginolyticus*, *V*. *parahaemolyticus* and *A*. *hydrophila* are all flagellated bacteria, TLR5M was up-regulated by 7.8-fold at 24 h after vaccination with trivalent bacterial vaccine. Eventually, its downstream signal transducers (TRAF6, IκBα, ERK), transcriptional factors (RelB, AP-1), and effectors (TNF-α, IL-6, IL-12, CCL4) were also up-regulated, indicating TLR5M mediated signaling pathway was activated by trivalent vaccine (**[Fig 3](#pone.0170958.g003){ref-type="fig"})**. Other signal transducers, such as IRAK1/4, TAK1, and IKKα/β/γ were changed slightly after vaccination, perhaps due to these genes play their roles through the changes in phosphorylation levels \[[@pone.0170958.ref044]\]. NLRP1 or NLRP3 can bind with their adaptor proteins ASC and capase-1 to form the inflammasome complex after recognizing corresponding ligands (LPS, Muramyl Dipeptide, or bacterial RNA), and then promote cleavage and secretion of biologically active pro-inflammatory cytokine IL-1β \[[@pone.0170958.ref045]--[@pone.0170958.ref047]\]. In this study, NLRP1, NLRP3, ASC, and IL-1β were significantly induced by vaccination (**[Fig 3](#pone.0170958.g003){ref-type="fig"}**), which may result in increase of the biologically active IL-1β to recruit inflammatory cells for eliminating pathogens. These results demonstrate that multiple innate immune processes were activated at the early stage of vaccination in large yellow croaker.

Spleen is a major secondary lymphoid organ in the fish, containing a large number of B cells, T cells, neutrophils, and macrophages. The Neutrophils and macrophages as antigen-presenting cells, possess heterogeneous intracellular pathways responsible for generating complexes of MHC class I and class II molecules with peptide antigens, for presentation to T cells \[[@pone.0170958.ref048]--[@pone.0170958.ref051]\]. Bacterial antigens are internalized into host cells via phagosomes or endosomes. Specifically, the antigenic peptides are degraded in the cytoplasm by proteasome, and then transported to the endoplasmic reticulum by TAP and loaded onto MHC-I molecules with the help of ERAP, TAP, TAPBP, and CLAR \[[@pone.0170958.ref052]\]. Antigenic peptides also can be captured and degraded in endosome and lysosome with the help of CTS, HSP70, and PPT2, and then loaded onto MHC-II molecules \[[@pone.0170958.ref053]\]. In our study, CTS, PPT2, CLAR, TAP, HSP70, and TAPBP were significantly up-regulated after vaccination (**[Fig 4](#pone.0170958.g004){ref-type="fig"}**), while slightly changes were found in the MHC-I and MHC-II expression levels (**[Table 3](#pone.0170958.t003){ref-type="table"}**). These results suggest that antigen processing may be activated at the early stage of vaccination, but the antigen presentation was in the process of being started.

Moreover, the expression levels of several genes involved in TCR signaling pathway, including TCRα, TCRβ, related CD molecules (CD3γ, CD4, and CD8β), and downstream signaling molecules (FYN, ZAP-70, PLC-γ1, PDK, and PKCθ), were down-regulated by trivalent bacterial vaccine (**[Table 3](#pone.0170958.t003){ref-type="table"}**), suggesting that the TCR signaling pathway may be suppressed at the early stage of vaccination. The similar results were also found in other teleost fish \[[@pone.0170958.ref022], [@pone.0170958.ref034], [@pone.0170958.ref054], [@pone.0170958.ref055]\]. In zebrafish, expression of TCR pathway-related genes was found to decrease at 24 h following immunization with attenuated *Edwardsiella tarda* vaccine \[[@pone.0170958.ref054]\]. In half-smooth tongue sole (*Cynoglossus semilaevis*), TCR pathway was suppressed at 20 h after *Vibrio anguillarum* infection \[[@pone.0170958.ref055]\]. Expression levels of TCRα, β, and δ in tilapia (*Oreochromis niloticus*) were down-regulated by *Streptococcus iniae* at 24 h post-infection \[[@pone.0170958.ref022]\]. In our previous study, TCR pathway was also suppressed at 24 h after *Aeromonas hydrophila* infection in large yellow croaker \[[@pone.0170958.ref034]\]. However, the mechanism by which TCR pathway was suppressed at the early period of immunization with bacterial vaccine or bacterial infection remains unknown.

In conclusion, transcriptome analysis was utilized to investigate the early immune response of large yellow croaker to bacterial vaccine immunization. The most of strongly up-regulated genes are innate defense molecules, bacterial ligand---depending PRRs, inflammatory factors, and antigen processing related molecules, indicating that multiple innate immune processes and acquired immune initiation were activated at the early stage of vaccination in large yellow croaker. However, TCR signaling pathway was suppressed after vaccination. The findings observed in this study are similar to immune responses of large yellow croaker infected by live *A*. *hydrophila*, implying that inactivated vaccine has the similar effects on induction of host defense by bacterial infection. These results comprehensively reveal the early immune response in the large yellow croaker induced by trivalent vaccine and provide valuable information for developing a highly immunogenic vaccine in teleosts.
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